Nobel Prize in Chemistry Awarded to Baker, Hassabis and Jumper for AI Protein Breakthroughs

The Royal Swedish Academy of Sciences in Stockholm announced on Wednesday that the 2024 Nobel Prize in Chemistry has been awarded to David Baker of the University of Washington, alongside Demis Hassabis and John Jumper of Google DeepMind, for groundbreaking achievements that transformed molecular biology through computation and artificial intelligence.

The prestigious award is divided into two distinct halves: one half goes to David Baker for computational protein design, while the other half is awarded jointly to Demis Hassabis and John Jumper for developing AlphaFold2, an AI model that predicts complex three-dimensional protein structures directly from linear amino acid sequences.

Mastering the Computational Design of Novel Proteins

David Baker achieved what many scientists once thought impossible by creating computational software called Rosetta to design entirely new proteins from scratch. Since his breakthrough in 2003, his research team has produced innovative synthetic proteins capable of serving as targeted pharmaceuticals, neutralizing deadly toxins, and functioning as microscopic molecular sensors.

Meanwhile, the problem of predicting how amino acid chains fold into complex three-dimensional shapes had vexed molecular biologists for over five decades. In 2020, Hassabis and Jumper introduced AlphaFold2, an artificial intelligence system that solved this grand challenge with atomic accuracy across virtually all 200 million identified proteins.

“One of the discoveries being recognised this year concerns the construction of spectacular proteins. The other is about fulfilling a 50-year-old dream: predicting protein structures from their amino acid sequences.” — Heiner Linke, Chair of the Nobel Committee for Chemistry

AlphaFold2 Solves a Fifty-Year Biological Grand Challenge

The impact of these dual discoveries is vast, transforming scientific laboratories worldwide. Over two million researchers across 190 countries have utilized AlphaFold database predictions to study antibiotic resistance, develop green enzymes that break down plastic pollutants, and understand cellular mechanisms driving human disease.

The Nobel Committee emphasized that combining computational creation with AI-powered structural prediction bridges fundamental chemistry and applied medicine, unlocking unprecedented opportunities for personalized treatments, vaccines, and sustainable nanotechnology.

Sources

• The Nobel Prize
• Royal Swedish Academy of Sciences